- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01253967
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
April 9, 2015 updated by: GlaxoSmithKline
Hospital-based Surveillance to Estimate the Disease Burden of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
The purpose of this hospital based study is to estimate the proportion of rotavirus gastroenteritis in children < 5 years of age in Romania.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study consist of a main study and a health economics study
Main study: The study will focus on three different groups of patients:
- Subjects who are hospitalised for acute gastroenteritis.
- Subjects who visit an emergency room for acute gastroenteritis.
- Subjects who have rotavirus positive laboratory results and developed acute gastroenteritis at least 48 hours after hospitalisation.
Health economics study: for a subset of subjects, additional economic data will be gathered by completing a questionnaire
Study Type
Observational
Enrollment (Actual)
1234
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bucharest, Romania, 021105
- GSK Investigational Site
-
Bucharest, Romania
- GSK Investigational Site
-
Cluj, Romania, 400348
- GSK Investigational Site
-
Cluj Napoca, Romania
- GSK Investigational Site
-
Constanta, Romania, 900708
- GSK Investigational Site
-
Craiova, Romania
- GSK Investigational Site
-
Sibiu, Romania
- GSK Investigational Site
-
Timisoara, Romania
- GSK Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children < 5 years of age treated at a hospital site (subjects hospitalised with community acquired acute gastroenteritis, subjects who visited the emergency room for acute gastroenteritis or subjects with medical care associated rotavirus infection).
Description
Inclusion Criteria:
- A male or female child aged < 5 years at the time of admission. A child becomes ineligible on the day of her/his fifth birthday.
A subject, who during the study period:
- Is hospitalised for acute gastroenteritis Or
- Visits an emergency room for acute gastroenteritis Or
- Has rotavirus positive laboratory results and develops acute gastroenteritis at least 48 hours after hospitalisation
Exclusion Criteria:
Not applicable
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group A
Subjects who are hospitalised for acute gastroenteritis
|
Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.
For a subset of subjects, additional economic data will be gathered by completing a questionnaire
|
Group B
Subjects who visit an emergency room for acute gastroenteritis
|
Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.
For a subset of subjects, additional economic data will be gathered by completing a questionnaire
|
Group C
Subjects who have rotavirus positive laboratory results and developed acute gastroenteritis at least 48 hours after hospitalisation.
|
Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.
For a subset of subjects, additional economic data will be gathered by completing a questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of rotavirus gastroenteritis among all acute gastroenteritis hospitalisations of children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Proportion of rotavirus gastroenteritis among all acute gastroenteritis emergency room visits for children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Incidence of medical care associated rotavirus gastroenteritis among all hospitalised children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Age distribution of children with rotavirus gastroenteritis
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Percentage of rotavirus genotypes amongst all isolated strains in children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Potential risk factors for rotavirus gastroenteritis
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Rotavirus gastroenteritis associated costs
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Proportion of acute gastroenteritis among all hospitalisations of children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Proportion of community acquired acute gastroenteritis among all emergency room visits for children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Seasonal distribution (if appropriate) of rotavirus among all children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Severity of rotavirus among all children < 5 years of age
Time Frame: At least 12 months from study
|
At least 12 months from study
|
Proportion of rotavirus gastroenteritis among all hospitalisations of children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Proportion of community acquired rotavirus gastroenteritis among all emergency room visits for children < 5 years of age
Time Frame: At least 12 months from study start
|
At least 12 months from study start
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Benea OE, Streinu-Cercel A, Dorobat C, Rugina S, Negrutiu L, Cupsa A, Duiculescu D, Chiriac C, Itu C, Prisacariu LJ, Iosif I. Efficacy and safety of darunavir (Prezista((R))) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study. Germs. 2014 Sep 1;4(3):59-69. doi: 10.11599/germs.2014.1057. eCollection 2014 Sep.
- Anca IA, Furtunescu FL, Plesca D, Streinu-Cercel A, Rugina S, Holl K. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania. Germs. 2014 Jun 2;4(2):30-40. doi: 10.11599/germs.2014.1053. eCollection 2014 Jun.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
January 1, 2010
Study Completion (Actual)
January 1, 2010
Study Registration Dates
First Submitted
November 30, 2010
First Submitted That Met QC Criteria
December 2, 2010
First Posted (Estimate)
December 6, 2010
Study Record Updates
Last Update Posted (Estimate)
April 13, 2015
Last Update Submitted That Met QC Criteria
April 9, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 110436
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections, Rotavirus
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesUnited States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesJapan
-
GlaxoSmithKlineCompletedRotavirus Infection | Rotavirus VaccinesUnited States
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesPhilippines
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesPhilippines
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesBelgium
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus Gastroenteritis
-
GlaxoSmithKlineCompletedInfections, Rotavirus | Rotavirus VaccinesJapan
-
GlaxoSmithKlineCompletedInfections, RotavirusUnited States
Clinical Trials on Collection of stool samples
-
Assistance Publique - Hôpitaux de ParisCompletedEnteropathy, Necrotizing EnterocolitisFrance
-
Yakult Honsha European Research Center, ESVHarmony Clinical Research BVBACompleted
-
Hospices Civils de LyonCompletedInflammatory Bowel DiseasesFrance
-
Centre Georges Francois LeclercEnteromeCompleted
-
GlaxoSmithKlineCompletedRotavirus Severe GastroenteritisSingapore
-
OncoHost Ltd.RecruitingHealthy | Non Small Cell Lung CancerUnited States
-
University Hospital, ToulouseRecruitingBladder Cancer | Urothelial CarcinomaFrance
-
Innovaderm Research Inc.RecruitingPlaque Psoriasis | Atopic Dermatitis | Hidradenitis Suppurativa | Palmoplantar Pustulosis | Acne | Chronic Hand EczemaCanada
-
Sohag UniversityCompletedAcne Vulgaris | Helicobacter Pylori InfectionEgypt
-
University of PittsburghCompletedTransplantationUnited States